Literature DB >> 32978300

Delineation of a molecularly distinct terminally differentiated memory CD8 T cell population.

J Justin Milner1, Hongtuyet Nguyen2, Kyla Omilusik2, Miguel Reina-Campos2, Matthew Tsai3, Clara Toma2, Arnaud Delpoux2, Brigid S Boland3, Stephen M Hedrick2,4, John T Chang3, Ananda W Goldrath1.   

Abstract

Memory CD8 T cells provide durable protection against diverse intracellular pathogens and can be broadly segregated into distinct circulating and tissue-resident populations. Paradigmatic studies have demonstrated that circulating memory cells can be further divided into effector memory (Tem) and central memory (Tcm) populations based on discrete functional characteristics. Following resolution of infection, we identified a persisting antigen-specific CD8 T cell population that was terminally fated with potent effector function but maintained memory T cell qualities and conferred robust protection against reinfection. Notably, this terminally differentiated effector memory CD8 T cell population (terminal-Tem) was conflated within the conventional Tem population, prompting redefinition of the classical characteristics of Tem cells. Murine terminal-Tem were transcriptionally, functionally, and developmentally unique compared to Tem cells. Through mass cytometry and single-cell RNA sequencing (RNA-seq) analyses of human peripheral blood from healthy individuals, we also identified an analogous terminal-Tem population of CD8 T cells that was transcriptionally distinct from Tem and Tcm Key findings from this study show that parsing of terminal-Tem from conventionally defined Tem challenge the reported characteristics of Tem biology, including enhanced presence in lymphoid tissues, robust IL-2 production, and recall potential, greater than expected homeostatic fitness, refined transcription factor dependencies, and a distinct molecular phenotype. Classification of terminal-Tem and clarification of Tem biology hold broad implications for understanding the molecular regulation of memory cell states and harnessing immunological memory to improve immunotherapies.

Entities:  

Keywords:  T cells; immunology; infection; memory T cells

Mesh:

Year:  2020        PMID: 32978300      PMCID: PMC7568335          DOI: 10.1073/pnas.2008571117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  KLRG1+ Effector CD8+ T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity.

Authors:  Dietmar Herndler-Brandstetter; Harumichi Ishigame; Ryo Shinnakasu; Valerie Plajer; Carmen Stecher; Jun Zhao; Melanie Lietzenmayer; Lina Kroehling; Akiko Takumi; Kohei Kometani; Takeshi Inoue; Yuval Kluger; Susan M Kaech; Tomohiro Kurosaki; Takaharu Okada; Richard A Flavell
Journal:  Immunity       Date:  2018-04-03       Impact factor: 31.745

Review 2.  Autoimmune effector memory T cells: the bad and the good.

Authors:  Priyadharshini Devarajan; Zhibin Chen
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.

Authors:  Rachel L Rutishauser; Gislâine A Martins; Sergey Kalachikov; Anmol Chandele; Ian A Parish; Eric Meffre; Joshy Jacob; Kathryn Calame; Susan M Kaech
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

Review 4.  Tissue-resident memory T cells.

Authors:  Jason M Schenkel; David Masopust
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

5.  Effector-like CD8⁺ T cells in the memory population mediate potent protective immunity.

Authors:  Janelle A Olson; Cameron McDonald-Hyman; Stephen C Jameson; Sara E Hamilton
Journal:  Immunity       Date:  2013-06-06       Impact factor: 31.745

6.  Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation.

Authors:  J Adam Best; David A Blair; Jamie Knell; Edward Yang; Viveka Mayya; Andrew Doedens; Michael L Dustin; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2013-02-10       Impact factor: 25.606

7.  Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.

Authors:  Lianjun Zhang; Benjamin O Tschumi; Isabel C Lopez-Mejia; Susanne G Oberle; Marten Meyer; Guerric Samson; Markus A Rüegg; Michael N Hall; Lluis Fajas; Dietmar Zehn; Jean-Pierre Mach; Alena Donda; Pedro Romero
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

Review 8.  Defining Memory CD8 T Cell.

Authors:  Matthew D Martin; Vladimir P Badovinac
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

9.  The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection.

Authors:  Claudia X Dominguez; Robert A Amezquita; Tianxia Guan; Heather D Marshall; Nikhil S Joshi; Steven H Kleinstein; Susan M Kaech
Journal:  J Exp Med       Date:  2015-10-26       Impact factor: 14.307

10.  Functional classification of memory CD8(+) T cells by CX3CR1 expression.

Authors:  Jan P Böttcher; Marc Beyer; Felix Meissner; Zeinab Abdullah; Jil Sander; Bastian Höchst; Sarah Eickhoff; Jan C Rieckmann; Caroline Russo; Tanja Bauer; Tobias Flecken; Dominik Giesen; Daniel Engel; Steffen Jung; Dirk H Busch; Ulrike Protzer; Robert Thimme; Matthias Mann; Christian Kurts; Joachim L Schultze; Wolfgang Kastenmüller; Percy A Knolle
Journal:  Nat Commun       Date:  2015-09-25       Impact factor: 14.919

View more
  18 in total

1.  Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.

Authors:  Ilkka Liikanen; Colette Lauhan; Sara Quon; Kyla Omilusik; Anthony T Phan; Laura Barceló Bartrolí; Amir Ferry; John Goulding; Joyce Chen; James P Scott-Browne; Jason T Yustein; Nicole E Scharping; Deborah A Witherden; Ananda W Goldrath
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

2.  Tissue-resident memory CD8+ T cells possess unique transcriptional, epigenetic and functional adaptations to different tissue environments.

Authors:  John T Crowl; Maximilian Heeg; Amir Ferry; J Justin Milner; Kyla D Omilusik; Clara Toma; Zhaoren He; John T Chang; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2022-06-27       Impact factor: 31.250

3.  A CD4+ T cell reference map delineates subtype-specific adaptation during acute and chronic viral infections.

Authors:  Thomas Ciucci; Santiago J Carmona; Massimo Andreatta; Ariel Tjitropranoto; Zachary Sherman; Michael C Kelly
Journal:  Elife       Date:  2022-07-13       Impact factor: 8.713

4.  Ubiquitin Specific Protease 1 Expression and Function in T Cell Immunity.

Authors:  Kyla D Omilusik; Marija S Nadjsombati; Tomomi M Yoshida; Laura A Shaw; John Goulding; Ananda W Goldrath
Journal:  J Immunol       Date:  2021-08-11       Impact factor: 5.426

5.  The long noncoding RNA Malat1 regulates CD8+ T cell differentiation by mediating epigenetic repression.

Authors:  Jad N Kanbar; Shengyun Ma; Eleanor S Kim; Nadia S Kurd; Matthew S Tsai; Tiffani Tysl; Christella E Widjaja; Abigail E Limary; Brian Yee; Zhaoren He; Yajing Hao; Xiang-Dong Fu; Gene W Yeo; Wendy J Huang; John T Chang
Journal:  J Exp Med       Date:  2022-05-20       Impact factor: 17.579

6.  The Extracellular ATP Receptor P2RX7 Imprints a Promemory Transcriptional Signature in Effector CD8+ T Cells.

Authors:  Trupti Vardam-Kaur; Sarah van Dijk; Changwei Peng; Kelsey M Wanhainen; Stephen C Jameson; Henrique Borges da Silva
Journal:  J Immunol       Date:  2022-03-09       Impact factor: 5.426

Review 7.  Metabolic regulation of tissue-resident memory CD8+ T cells.

Authors:  Trupti Vardam-Kaur; Jie Sun; Henrique Borges da Silva
Journal:  Curr Opin Pharmacol       Date:  2021-03-11       Impact factor: 5.547

8.  Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection.

Authors:  J Justin Milner; Clara Toma; Sara Quon; Kyla Omilusik; Nicole E Scharping; Anup Dey; Miguel Reina-Campos; Hongtuyet Nguyen; Adam J Getzler; Huitian Diao; Bingfei Yu; Arnaud Delpoux; Tomomi M Yoshida; Deyao Li; Jun Qi; Adam Vincek; Stephen M Hedrick; Takeshi Egawa; Ming-Ming Zhou; Shane Crotty; Keiko Ozato; Matthew E Pipkin; Ananda W Goldrath
Journal:  J Exp Med       Date:  2021-05-26       Impact factor: 14.307

9.  Inhibiting BRD4 to generate BETter T cell memory.

Authors:  Moujtaba Y Kasmani; Weiguo Cui
Journal:  J Exp Med       Date:  2021-06-16       Impact factor: 17.579

10.  Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis.

Authors:  Yao Jin; Aili Tan; Jia Feng; Zexi Xu; Peiwei Wang; Peng Ruan; Ruijun Luo; Yiming Weng; Min Peng
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.